WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: FEBRUARY ISSUE PUBLISHED
  • FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

Abstract

REVIEW ON AMINOGLYCOSIDES: A COMPHREHENSIVE REVIEW OF MECHANISM, CLINICAL EFFICACY AND FUTURE PROSPECTS

Prof. Mansi Bhosale, Mehreen Khan*, Shaziya Kazi, Vishakha Kolekar, Soham Kaware, Isha Kuwara

ABSTRACT

Aminoglycosides are an important group of antibiotics mainly used to treat serious infections caused by aerobic Gram-negative bacteria. They are valued for their rapid and strong bactericidal action and their synergistic effect when combined with other antibiotics. These drugs act by irreversibly binding to the 30S ribosomal subunit, leading to inhibition of protein synthesis, misreading of mRNA, and bacterial cell death. Pharmacokinetically, aminoglycosides show poor oral absorption, limited tissue penetration, renal elimination, concentration-dependent killing, and a prolonged post-antibiotic effect, which influence dosing and monitoring. They are commonly used in life-threatening infections such as septicemia, pneumonia, urinary tract infections, intra-abdominal infections, and tuberculosis, but their use is restricted due to major adverse effects, especially nephrotoxicity and ototoxicity. Resistance develops through enzymatic inactivation, reduced uptake, and ribosomalalterations, prompting research into newer derivatives, optimized dosing, drug delivery systems, and combination therapies to reduce toxicity and overcome resistance in the era of rising antimicrobial resistance.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More